BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study)
NCT02398929
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Bisoprolol 2.5 mg
DRUG:
Placebo
Sponsor
Chinese University of Hong Kong